Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia
EB Belachew, AF Desta, TY Gebremariam… - Frontiers in …, 2023 - frontiersin.org
Purpose Different biological characteristics, therapeutic responses, and disease-specific
outcomes are associated with different molecular subtypes of breast cancer (BC). Although …
outcomes are associated with different molecular subtypes of breast cancer (BC). Although …
Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania
LP Rweyemamu, BK Gültaşlar, G Akan… - Cancer …, 2023 - Wiley Online Library
Background Growing prevalence and aggressiveness of breast cancer (BC) among East
African women strongly indicate that the genetic risk factor implicated in the etiology of the …
African women strongly indicate that the genetic risk factor implicated in the etiology of the …
Association of risk factors and breast cancer among women treated at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a case–control study
F Hassen, F Enquselassie, A Ali, A Addissie, G Taye… - BMJ open, 2022 - bmjopen.bmj.com
Objectives Many factors known to increase the risk of breast cancer, such as age, family
history, early menarche and late menopause are not modifiable. Modifiable factors include …
history, early menarche and late menopause are not modifiable. Modifiable factors include …
The interplay between XPG‐Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction …
Background Reproductive history and genetics are well‐known risk factors of breast cancer
(BC). Little is known about how these factors interact to effect BC. This study investigated the …
(BC). Little is known about how these factors interact to effect BC. This study investigated the …
A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
D Raihan - 2023 - dspace.bracu.ac.bd
Cancer stands among the most serious causes of mortality internationally. These therapies
are one of the most tough in today's globe. As a result, it has a unique complexity, risk …
are one of the most tough in today's globe. As a result, it has a unique complexity, risk …
Prevalencia, factores de riesgo y tratamiento del cáncer luminal de mama
JE Carrasco Alvarado - 2022 - dspace.ucacue.edu.ec
ANTECEDENTES: el cáncer mamario es una neoplasia con una gran variabilidad clínica y
biológica; gracias al análisis molecular se ha logrado clasificar el cáncer de mama en …
biológica; gracias al análisis molecular se ha logrado clasificar el cáncer de mama en …
Cáncer de mama. Actualización diagnóstica histopatológica y molecular
GE Chicaiza Jácome - 2022 - dspace.ucacue.edu.ec
ANTECEDENTES: el cáncer de mama (CM) es una de las formas neoplásicas que ha ido
en aumento en todo el mundo y que tiene amplia influencia en la mortalidad y morbilidad de …
en aumento en todo el mundo y que tiene amplia influencia en la mortalidad y morbilidad de …
The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction …
Background Reproductive history and genetics are well-known risk factors of breast cancer
(BC). Little is known about how these factors interact to effect BC. This study investigated the …
(BC). Little is known about how these factors interact to effect BC. This study investigated the …
[PDF][PDF] Epidemiology, risk factors and molecular subtypes of Breast Carcinoma
MI El Dosoky, SM Fadel, MASAM Mohamed - iscientific.org
Breast cancer (BC) is the leading cause of cancer-related death among women and the
most commonly diagnosed cancer worldwide. The 5-year overall survival (OS) from BC has …
most commonly diagnosed cancer worldwide. The 5-year overall survival (OS) from BC has …
[PDF][PDF] Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer
AH Mohammed, SM Khallaf, AM Hefni - secioj.journals.ekb.eg
Background: Breast cancer holds a wide spectrum of heterogeneity in terms of gene
expression, immunophenotypes, treatment response and clinical outcomes. Metastatic …
expression, immunophenotypes, treatment response and clinical outcomes. Metastatic …